ArticleThe Kaohsiung journal of medical sciences2020

miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer.

Qing-Lan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.